The burden of influenza is unevenly distributed, with more severe outcomes in children
aged< 5 years than older children and adults. In spite of this, immunisation policies for …

Immunization implementation in the community relies upon post-licensure vaccine safety
surveillance to maintain safe vaccination programs and to detect rare AEFI not observed in …

Background Commonly used trivalent vaccines contain one influenza B virus lineage and
may be ineffective against viruses of the other B lineage. We evaluated the efficacy of a …

METHODS: We examined the risk of FS 0 to 1 day postvaccination for all routinely
recommended vaccines among children aged 6 through 23 months during a period …

ABSTRACT A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-
Saharan Africa showed RTS, S/AS01 vaccine efficacy against malaria. We now present in …

Introduction Studies on quadrivalent measles, mumps, rubella, and varicella (MMRV)
vaccines have indicated a twofold increased relative risk of febrile convulsion (FC) after the …

BACKGROUND: There are few studies evaluating the effectiveness of trivalent influenza
vaccination (TIV) in young children, particularly in children< 2 years. The Western Australian …

Since the 1960s, pregnant women in the United States have been recommended to receive
influenza vaccine. A maternal concern about the possibility of adverse fetal and neonatal …

Abstract Background In 2017, Australia experienced record influenza notifications. Two
surveillance programs combined to summarize the epidemiology of hospitalized influenza in …

Most influenza vaccines are generally safe, but influenza vaccines can cause rare serious
adverse events. Some adverse events, such as fever and febrile seizures, are more common …